More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$7.10B
EPS
2.66
P/E ratio
30
Price to sales
5.18
Dividend yield
--
Beta
0.210988
Previous close
$84.61
Today's open
$85.06
Day's range
$84.51 - $86.35
52 week range
$72.76 - $106.60
show more
CEO
Scott Cutler
Employees
3120
Headquarters
Draper, UT
Exchange
Nasdaq Global Select
Shares outstanding
83602157
Issue type
Common Stock
Healthcare
Healthcare Providers & Services
Here's Why HealthEquity (HQY) is a Strong Growth Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks Investment Research • Jun 19, 2026

Reasons to Hold HealthEquity Stock in Your Portfolio for Now
HQY benefits from strong HSA growth, AI-driven automation and solid first-quarter fiscal 2027 results despite data security risks.
Zacks Investment Research • Jun 12, 2026

Is HealthEquity's Improving Profitability Enough to Offset Key Risks?
HQY raises fiscal 2027 guidance after strong Q1 results, but custodial yield swings and cybersecurity worries remain.
Zacks Investment Research • Jun 11, 2026

One in Three Americans Delay Medical Care Due to Cost, HealthEquity Research Finds
Healthcare Cost Pressures Drive Workplace Productivity Losses; HSA Holders Report Stronger Confidence and Control Healthcare Cost Pressures Drive Workplace Productivity Losses; HSA Holders Report Stronger Confidence and Control
GlobeNewsWire • Jun 8, 2026

3 Medical Service Industry Stocks Thriving Amid Workforce Challenges
BTSG, BDSX and HQY stand to benefit as digital health, healthcare analytics and nursing care growth offset workforce strains.
Zacks Investment Research • Jun 8, 2026

Why HealthEquity (HQY) is a Top Momentum Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks Investment Research • Jun 4, 2026

Wall Street Analysts See a 33.49% Upside in HealthEquity (HQY): Can the Stock Really Move This High?
The consensus price target hints at a 33.5% upside potential for HealthEquity (HQY). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Zacks Investment Research • Jun 4, 2026

3 Reasons Why Growth Investors Shouldn't Overlook HealthEquity (HQY)
HealthEquity (HQY) possesses solid growth attributes, which could help it handily outperform the market.
Zacks Investment Research • Jun 4, 2026

Why HealthEquity (HQY) is a Top Growth Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks Investment Research • Jun 3, 2026

HealthEquity, Inc. (HQY) Q1 2027 Earnings Call Transcript
HealthEquity, Inc. (HQY) Q1 2027 Earnings Call Transcript
Seeking Alpha • May 29, 2026

¹ Disclosures

Open an M1 investment account to buy and sell HealthEquity Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.